Healthcare - Medical - Instruments & Supplies - NYSE - CA
$ 19.68
0.562 %
$ 6.93 B
Market Cap
-18.92
P/E
BALANCE SHEET
13.4 B
ASSETS
6.52 B
LIABILITIES
6.85 B
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Bausch + Lomb Corporation
| Current Assets | 2.74 B |
| Cash & Short-Term Investments | 331 M |
| Receivables | 839 M |
| Other Current Assets | 1.57 B |
| Non-Current Assets | 10.7 B |
| Long-Term Investments | 0 |
| PP&E | 1.39 B |
| Other Non-Current Assets | 9.31 B |
| Current Liabilities | 1.58 B |
| Accounts Payable | 522 M |
| Short-Term Debt | 30 M |
| Other Current Liabilities | 1.03 B |
| Non-Current Liabilities | 4.94 B |
| Long-Term Debt | 4.62 B |
| Other Non-Current Liabilities | 324 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | ||
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 331.0 | 354.0 | 174.0 | 238.0 | 192.0 | |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 | |
| Receivables | 839.0 | 724.0 | 721.0 | 645.0 | 713.0 | |
| Inventory | 1 028.0 | 628.0 | 572.0 | 616.0 | 592.0 | |
| Other Current Assets | 544.0 | 431.0 | 168.0 | 155.0 | 198.0 | |
| Total Current Assets | 2 742.0 | 2 137.0 | 1 635.0 | 1 654.0 | 1 695.0 | |
| PP&E | 1 390.0 | 1 300.0 | 1 225.0 | 1 164.0 | 997.0 | |
| Intangible Assets | 3 589.0 | 2 058.0 | 2 264.0 | 2 562.0 | 2 855.0 | |
| Goodwill | 4 575.0 | 4 507.0 | 4 586.0 | 4 685.0 | 4 554.0 | |
| Long Term Investments | 0 | 12.0 | 0 | 0 | 0 | |
| Other Long Term Assets | 225.0 | 203.0 | 180.0 | 165.0 | 175.0 | |
| Other Assets | 0 | 0 | 0 | 0 | 0 | |
| Total Assets | 13 442.0 | 11 144.0 | 10 823.0 | 11 266.0 | 11 468.0 | |
| LIABILITIES | ||||||
| Accounts Payable | 522.0 | 370.0 | 239.0 | 178.0 | 262.0 | |
| Short Term Debt | 30.0 | 25.0 | 28.0 | 0 | 0 | |
| Other Current Liabilities | 1 027.0 | 901.0 | 832.0 | 730.0 | 735.0 | |
| Total Current Liabilities | 1 579.0 | 1 296.0 | 1 099.0 | 909.0 | 1 035.0 | |
| Long Term Debt | 4 619.0 | 2 503.0 | 0 | 0 | 0 | |
| Deferred Tax Income | 14.0 | 7.0 | 24.0 | 27.0 | 38.0 | |
| Other Liabilities | 310.0 | 237.0 | 322.0 | 369.0 | 401.0 | |
| Total Liabilities | 6 522.0 | 4 043.0 | 1 421.0 | 1 278.0 | 1 436.0 | |
| EQUITY | ||||||
| Common Stock | 0 | 0 | 10 364.0 | 10 807.0 | 11 005.0 | |
| Retained Earnings | (254.0) | 6.0 | 0 | 0 | 0 | |
| Other Accumulative Comprehensive Income/Loss | (1 245.0) | (1 258.0) | (1 035.0) | (889.0) | (1 046.0) | |
| Total Equity | 6 920.0 | 7 101.0 | 9 402.0 | 9 988.0 | 10 032.0 | |
| Total Liabilities and Equity | 13 442.0 | 11 144.0 | 10 823.0 | 11 266.0 | 11 468.0 | |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 350.5 | 350.0 | 350.0 | 350.0 | 350.0 | 350.0 |